Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [843]
News [2101]
Articles [21]
Editorials [1]
Conferences [129]
elearning [2]
Screening to identify unsuitable candidates for ipilimumab in advanced melanoma
Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy
Screening to identify unsuitable candidates for ipilimumab in advanced melanoma ( Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy )
9 Jun 2015
Nivolumab alone superior to ipilimumab alone in advanced melanoma
Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy
Nivolumab alone superior to ipilimumab alone in advanced melanoma ( Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy )
8 Jun 2015
Adjuvant denosumab may preserve bone health in postmenopausal breast cancer...
Prof Michael Gnant - Medical University of Vienna, Vienna, Austria
Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )
1 Jun 2015
Initial nivolumab-based treatment halts melanoma progression
Dr Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Initial nivolumab-based treatment halts melanoma progression ( Dr Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
1 Jun 2015
Advanced DNA sequencing test used to match rare cancers
Dr James Doroshow, Dr Keith Flaherty and Dr Barbara Conley
Advanced DNA sequencing test used to match rare cancers ( Dr James Doroshow, Dr Keith Flaherty and Dr Barbara Conley )
1 Jun 2015
Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia...
Dr William Slayton - University of Florida, Gainsville, USA
Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL ( Dr William Slayton - University of Florida, Gainsville, USA )
1 Jun 2015
Raloxifene retained approximately 81% of the effectiveness of tamoxifen in...
Dr Lawrence Wickerham - NRG Oncology Research Group, Pittsburgh, USA
Raloxifene retained approximately 81% of the effectiveness of tamoxifen in preventing invasive breast cancer ( Dr Lawrence Wickerham - NRG Oncology Research Group, Pittsburgh, USA )
31 May 2015
Next generation inhibitors help overcome problems of resistance in ALK positive...
Dr Ross Camidge - University of Colorado, Denver, USA
Next generation inhibitors help overcome problems of resistance in ALK positive lung cancer ( Dr Ross Camidge - University of Colorado, Denver, USA )
31 May 2015
Letrozole vs observation for HR positive breast cancer
Dr Nicholas Zdenkowski - University of Newcastle, Newcastle, Australia
Letrozole vs observation for HR positive breast cancer ( Dr Nicholas Zdenkowski - University of Newcastle, Newcastle, Australia )
31 May 2015
Phase III study finds initial nivolumab-based treatment halts melanoma...
Dr Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Phase III study finds initial nivolumab-based treatment halts melanoma progression ( Dr Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
31 May 2015
Ibrutinib combination regimen shows substantial benefits in relapsed CLL
Dr Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA
Ibrutinib combination regimen shows substantial benefits in relapsed CLL ( Dr Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA )
30 May 2015
Developing technical improvements to bladder radiotherapy using online imaging
Dr Robert Huddart - Institute of Cancer Research, London, UK
Developing technical improvements to bladder radiotherapy using online imaging ( Dr Robert Huddart - Institute of Cancer Research, London, UK )
20 May 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation